Xuanwu hospital
Beijing, Beijing Municipality, 100053, China
Location contact
Tianlong Wang, Doctor
CONTACT
15910851623 ext. 15910851623
Yanghai Cui, PHD
CONTACT
83199270 ext. 15010283592
NCT Number: NCT06662656
1. Sufentanil as an strong analgesic is used widespreadly during laparoscopic cholecystectomy. 2. Lower dosages of sufentanil facilitated with dexmedetomidine can offer enough analgesia effect. 3. The investigator are planning use the most classical method for determining the ED50 or half effective concentration of sufentanil facilitated with dexmedetomidine using sequential method, which is also called" up and down method" and" ladder method".
Trial opening soon.
Get Notified18 year–65 year
All sexes
Observational
Beijing, Beijing Municipality, 100053, China
Tianlong Wang, Doctor
CONTACT
15910851623 ext. 15910851623
Yanghai Cui, PHD
CONTACT
83199270 ext. 15010283592
The concordance of the current research is that lower dosages of sufentanil facilitated with dexmedetomidine can offer enough analgesia effect through operation. However, the dosages of sufentanil used in various researches vary greatly of operations. Previous studies have shown that the amount of sufentanil required for intraoperative analgesia is smaller than that required while dexmedetomindine facilitated. Although the appropriate dosage of sufentanil required for operation can ensure the analgesic effect of operation, excessive dosage can cause severe choking during intubation, postoperative nausea and vomiting, hyperalgesia, and chronic postoperative pain. The investigator planning use the most classical method for determining the ED50 or half effective concentration of sufentainl combined with dexmedetomidine using sequential method, which is also called " up and down method" and " ladder method".
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, an average of 1 day
The primary endpoint of the study was the attainment rate of the IOC2 target during operation
Time frame: 12 hours and 24hours after surgery
visual analog scale (VAS) score at 12 h and 24 hours after operation,
Time frame: 0 day, 1 day, 2 day after operation
the ratio of vomiting
Time frame: 0 day
Systolic Blood Pressure reflect haemodynamics changeduring operation
Time frame: 0 day
Dystolic Blood Pressure during operation
Time frame: 0 day
Mean Blood Pressure during opeation
Time frame: 0 day
Heart rate during operation
China International Neuroscience Institution
Other
ED50 of Sufentanil with Dexmedetomidine Analgesia During Laparoscopic Cholecystectomy
Acronym: ED50
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07589491
Intertransverse Process Block, Laparoscopic Cholecystectomy
View Trial DetailsNCT07647770
Laparoscopic Cholecystectomy, Mechanical Ventilation
Khobar, Eastern Province, Saudi Arabia
View Trial DetailsNCT07625137
Adnexal Diseases, Endocrine Gland Neoplasms
Langley, British Columbia, Canada
View Trial DetailsNCT07566819
Benign Gallbladder Disease, Laparoscopic Cholecystectomy
View Trial Details